FORM
6-K
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Report
of Foreign Issuer
Pursuant
to Rule 13a-16 or 15d-16
of
the Securities Exchange Act of 1934
For the
month of June 2008
Commission
File Number: 001-15152
SYNGENTA
AG
(Translation
of registrant’s name into English)
Schwarzwaldallee
215
4058
Basel
Switzerland
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under
cover of Form 20-F or Form 40-F:
|
Form
20-F
|
X
|
Form
40-F
|
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(1):
|
Yes
|
|
No
|
X
|
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(7):
|
Yes
|
|
No
|
X
|
Indicate
by check mark whether by furnishing the information contained in this Form, the
Registrant is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
|
Yes
|
|
No
|
X
|
If “Yes”
is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b): N/A
Re: SYNGENTA
AG
Press
Release: "Du Pont and Syngenta
enter into crop protection technology exchange”
Filed
herewith is a press release related to Syngenta AG. The full text of the press
release follows:
# #
#
|
Syngenta International AG
|
Media contacts: | Analyst/Investor contacts: | |||
| Media Office | Médard Schoenmaeckers | Jennifer Gough | |||
| CH-4002 Basel | Switzerland | +41 61 323 2323 | Switzerland | +41 61 323 5059 | |
| Switzerland | USA | +1 202 737 6521 | |||
| Tel: | +41 61 323 23 23 | Anne Burt | |||
| Fax: |
+41 61 323 24
24
|
USA | +1 202 628 2372 | Jonathan Seabrook | |
| Switzerland | +41 61 323 7502 | ||||
|
www.syngenta.com
|
USA | +1 202 737 6520 | |||
 |
 |
DuPont
and Syngenta enter into crop protection technology exchange
Syngenta and DuPont
today announced an agreement that will broaden each company’s crop protection
product portfolios and enable them to bring new products to market more
efficiently.
The companies will
share the costs to prepare the regulatory studies for DuPont Cyazypyr™, a new
broad spectrum insecticide for the control of lepidoptera and sucking pests,
leading to expanded global registrations and commercialization opportunities for
both companies. Cyazypyr™ is complementary to the DuPont Rynaxypyr® insect
control product that Syngenta is developing in mixtures with its own leading
insect control products.
Under the agreement,
Syngenta will also grant DuPont access to mesotrione, the active ingredient in
Callisto®. DuPont
will develop mixtures with their proprietary herbicides for use on corn and
sugarcane.
John Atkin, Chief
Operating Officer Syngenta Crop Protection said: “This agreement gives Syngenta
access to new chemistry to develop broad spectrum solutions in the global
insecticide market, estimated at around $8 billion. These products, which are
highly complementary to our portfolio and pipeline, will provide additional
options for growers to better control pests and increase yields. The mesotrione
agreement further expands the opportunity for this market leading
technology.”
“This is another
external acknowledgement of the quality of the DuPont pipeline of crop
protection products, as well as an innovative step in the DuPont strategy to
bring new pipeline products to our customers faster and with broader labels than
ever before,” said James C. Collins, vice president and general manager of
DuPont Crop Protection. “This agreement expands our offerings and enables DuPont
to make additional investments in our future pipeline to deliver answers that
will help our customers improve their productivity and profitability both today
and in the future.”
Financial terms of
the agreement were not disclosed.
Syngenta – June 24,
2008 / Page 1 of 3
Syngenta is a
world-leading agribusiness committed to sustainable agriculture through
innovative research and technology. The company is a leader in crop protection,
and ranks third in the high-value commercial seeds market. Sales in 2007 were
approximately $9.2 billion. Syngenta employs over 21,000 people in more than
90 countries. Syngenta is listed on the Swiss stock exchange (SYNN) and in
New York (SYT). Further information is available at www.syngenta.com.
DuPont is a
science-based products and services company. Founded in 1802, DuPont puts
science to work by creating sustainable solutions essential to a better, safer,
healthier life for people everywhere. Operating in more than 70 countries,
DuPont offers a wide range of innovative products and services for markets
including agriculture and food; building and construction; communications; and
transportation.
DuPont™, Rynaxypyr® and Cyazapyr™ are registered trademarks of DuPont
or its affiliates.
DuPont Media
contact:
Doyle
Karr
+1 515 270
3428
doyle.a.karr-1@usa.dupont.com
DuPont
Forward-Looking Statements
This news release
contains forward-looking statements based on management’s current expectations,
estimates and projections. All statements that address expectations or
projections about the future, including statements about the company’s strategy
for growth, product development, market position, expected expenditures and
financial results are forward-looking statements. Some of the forward-looking
statements may be identified by words like “expects,” “anticipates,” “plans,”
“intends,” “projects,” “indicates,” and similar expressions. These statements
are not guarantees of future performance and involve a number of risks,
uncertainties and assumptions. Many factors, including those discussed more
fully elsewhere in this release and in DuPont’s filings with the Securities and
Exchange Commission, particularly its latest annual report on Form 10-K, as well
as others, could cause results to differ materially from those stated. These
factors include, but are not limited to changes in the laws, regulations,
policies and economic conditions of countries in which the company does
business; competitive pressures; successful integration of structural changes,
including acquisitions, divestitures and alliances; research and development of
new products, including regulatory approval and market acceptance, and
seasonality of sales of agricultural products.
Syngenta – June 24,
2008 / Page 2 of 3
Syngenta
Cautionary Statement Regarding Forward-Looking Statements
This document
contains forward-looking statements, which can be identified by terminology such
as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’,
‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to
risks and uncertainties that could cause the actual results to differ materially
from these statements. We refer you to Syngenta's publicly available filings
with the U.S. Securities and Exchange Commission for information about these and
other risks and uncertainties. Syngenta assumes no obligation to update
forward-looking statements to reflect actual results, changed assumptions or
other factors. This document does not constitute, or form part of, any offer or
invitation to sell or issue, or any solicitation of any offer, to purchase or
subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it
form the basis of, or be relied on in connection with, any contract
therefor.
Syngenta – June 24,
2008 / Page 3 of 3
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
SYNGENTA AG
|
||||||
|
Date:
|
June
24, 2008
|
By:
|
/s/ Christoph Mäder | |||
|
Name:
|
Christoph
Mäder
|
|||||
|
Title:
|
Head
Legal and Taxes
|
|||||